Crossmark

Anatomic lung resection after target therapy or immune checkpoint inhibitors treatment for initially unresectable advanced-staged non-small cell lung cancer: a case series

Crossref DOI link: https://doi.org/10.1007/s13304-024-02026-8

Published Online: 2024-11-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mangiameli, Giuseppe https://orcid.org/0000-0002-8394-2719
Giudici, Veronica Maria

Brascia, Debora

Voulaz, Emanuele

Cariboni, Umberto

Toschi, Luca

Alloisio, Marco

Marulli, Giuseppe
License Information

Text and Data Mining valid from 2024-11-21

Version of Record valid from 2024-11-21
More Information

Article History

Received: 17 June 2024

Accepted: 16 October 2024

First Online: 21 November 2024

Declarations

:

: There was no conflict of interest with any laboratory concerning the care to the patient.

: This study complies with the Declaration of Helsinki.

: An informed consent was obtained from all participant in the study.

Document is current

Any future updates will be listed below